FDA Approves Expanded Uses for GARDASIL To Include Preventing Certain Vulvar and Vaginal Cancers

September 12, 2008 - The U.S. Food and Drug Administration today announced the approval of the v...  More »

September 12, 2008 - The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.  « Less